title: Treatment for lupus, first in 50 years, offers modest benefits, hope to patients.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D001741:Black or African American; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D017277:Drug Approval; D016527:Drug Costs; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000208:ethnology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C511911:belimumab